about
Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosisDownregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes.The endocannabinoid system as an emerging target of pharmacotherapyEvidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunitMutation screening of two candidate genes from 13q32 in families affected with Bipolar disorder: human peptide transporter (SLC15A1) and human glypican5 (GPC5)Npas4: a neuronal transcription factor with a key role in social and cognitive functions relevant to developmental disorders.Genome-wide association study identifies a susceptibility locus for schizophrenia in Han Chinese at 11p11.2Is lead exposure in early life an environmental risk factor for Schizophrenia? Neurobiological connections and testable hypotheses.Identification of targeted analyte clusters for studies of schizophrenia.NMDA receptor phosphorylation at a site affected in schizophrenia controls synaptic and behavioral plasticity.Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia.The myelin-pathogenesis puzzle in schizophrenia: a literature review.How frequent is chronic multiyear delusional activity and recovery in schizophrenia: a 20-year multi-follow-upAssessing social-cognitive deficits in schizophrenia with the Mayer-Salovey-Caruso Emotional Intelligence Test.TCF7L2 polymorphisms and the risk of schizophrenia in the Chinese Han populationNegative symptoms of schizophrenia correlate with impairment on the University of Pennsylvania smell identification testLong range frontal/posterior phase synchronization during remembered pursuit task is impaired in schizophrenia.Cognitive enhancement therapy improves emotional intelligence in early course schizophrenia: preliminary effects.Schizophrenia: neural mechanisms for novel therapiesReplication study confirms link between TSPAN18 mutation and schizophrenia in Han ChineseThe endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism--or inverse agonism--as potential obesity treatment and other therapeutic use.Comparative evaluation of forced swim test and tail suspension test as models of negative symptom of schizophrenia in rodents.Schizophrenia endophenotypes as treatment targets.Foresight in schizophrenia: a potentially unique and relevant factor to functional disability.Can the role of genetic factors in schizophrenia be enlightened by studies of candidate gene mutant mice behaviour?Effects of Severe Mental Illness Education on MSW Student Attitudes About Schizophrenia.Thalamic miR-338-3p mediates auditory thalamocortical disruption and its late onset in models of 22q11.2 microdeletion.Controversies surrounding the diagnosis of schizophrenia and other psychoses.Problems and promise of immunological factors as biomarkers for schizophrenia.Associations between Chlamydophila infections, schizophrenia and risk of HLA-A10.Modeling heterogeneous patients with a clinical diagnosis of schizophrenia with induced pluripotent stem cells.Progress in genome-wide association studies of schizophrenia in Han Chinese populations.Common variants on 2p16.1, 6p22.1 and 10q24.32 are associated with schizophrenia in Han Chinese population.Effects of Cognitive Enhancement Therapy on Employment Outcomes in Early Schizophrenia: Results From a Two-Year Randomized TrialBrain RGS4 and RGS10 protein expression in schizophrenia and depression. Effect of drug treatment.Abnormalities of presynaptic protein CDCrel-1 in striatum of rats reared in social isolation: relevance to neural connectivity in schizophrenia.Label-free quantitative proteomic analysis reveals dysfunction of complement pathway in peripheral blood of schizophrenia patients: evidence for the immune hypothesis of schizophrenia.Human genetic variation and mental disorders.Infusions of Nerve Growth Factor Into the Developing Frontal Cortex Leads to Deficits in Behavioral Flexibility and Increased Perseverance.Striatal mitochondria in subjects with chronic undifferentiated vs. chronic paranoid schizophrenia.
P2860
Q21144689-1FC05AF9-3B69-4240-8B3B-955CBDFD08A4Q24631189-75987F78-456B-41C7-82CE-C377B59CD134Q24648473-E44DE208-4087-464F-B128-A5A787A9EC3AQ24678549-F5E4AE3D-CC76-4B1A-B354-032117F879C2Q24795227-C8F306BB-42D3-4B41-896B-D15EAFE8C6EFQ28389182-78C60055-C1A1-4426-8420-348F4EA7CF28Q28943275-6B67D91D-1734-4001-A1E8-71A7A4123E2BQ30454141-6F75A1CF-5246-4BF6-B5CC-A835F64BD16BQ30476776-EE9210DB-104F-4903-9E96-CBAA9949CECCQ30484119-9FA6861D-2562-4539-8DBE-E209CE3E7107Q33187603-BB3E04B9-AE22-4FC8-B82F-94D118A4A28BQ33344726-F8D0C0D3-C18F-4F53-867E-CF00DE5E7195Q33566091-87289849-7394-40BC-8481-9C83FAD597CDQ33707629-62E0560F-9B16-4B1D-A231-7102F5D1D72BQ33709807-BB78A705-C48E-46F1-AF68-B235402D5DA9Q33780995-FD08755D-F464-472D-8E3C-0A9628A367ACQ34023235-D4DA0006-2017-4324-930E-4E2FEEB254CFQ34065772-3F0F7AC9-5852-420C-B96E-805086E5A755Q34520335-5C746C9A-49EA-419F-B1CC-330CAC8D056FQ34626055-8A2FE893-5932-4632-8C1D-625AD3E76406Q34626755-B0F27917-A2BF-4FB1-9922-8FC31C882320Q36857678-6F4C9E20-5281-43CA-87A6-F6B339B1E9B6Q36936347-D7312906-B1B9-4E5C-AFC7-AAD3FF422D05Q37009121-F3C78FB6-E90D-4708-8286-9DAB96573E94Q37461063-DF27E5F2-1019-4D0A-8950-F2DF46E416C1Q37506050-1CC29BFA-6CC2-4556-976B-D72A22FD855CQ37568618-A8466F9E-FEDF-4A68-BBA0-8D6C4A75746FQ37615360-7BA8A47D-1461-4D79-8ECD-452003880EC3Q37755088-593D0B9D-AD3A-4264-97A9-89D816B7174FQ37860923-2EF6879F-3393-4D89-AF99-6D4B09E78E57Q38170728-EFB626D4-D8F2-4228-97CE-9BC1692D3138Q38644092-3FD0F3D9-673F-4455-A738-ADE5A5D5E2FAQ39127101-D89BC926-5209-4D4A-B39F-CE8F34ECDCE8Q42735871-9596A943-CC23-4704-82DB-CFCC2CE714FBQ43509575-71C92494-312C-4262-8609-DDDE62F77A18Q44971614-96941B04-11EE-486D-9D28-DFB221C963E0Q47383429-29467A27-96CF-40A8-9580-2E4FC034A590Q48306545-70216626-DB33-4B39-B434-BC95F9E812E4Q48593032-5FB068EC-010A-4304-B62F-F40A556D1E92Q48908767-4F8D1CFE-2F14-4A5B-BD35-9FC2FC6E9EC2
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Advances in schizophrenia.
@ast
Advances in schizophrenia.
@en
Advances in schizophrenia.
@nl
type
label
Advances in schizophrenia.
@ast
Advances in schizophrenia.
@en
Advances in schizophrenia.
@nl
prefLabel
Advances in schizophrenia.
@ast
Advances in schizophrenia.
@en
Advances in schizophrenia.
@nl
P356
P1433
P1476
Advances in schizophrenia.
@en
P2093
Carpenter WT Jr
P2888
P304
P356
10.1038/89040
P407
P577
2001-06-01T00:00:00Z